Pharma Disease Insights: Oncology   Document Bundle
$299.00

THIS IS A DOCUMENT BUNDLE.

A bundle is a pre-defined set of documents. By purchasing the document bundle as a whole, you achieve significant savings from purchasing the documents individually. There is sometimes duplicate content among the bundled documents. See full details below.

Pharma Disease Insights: Oncology (Document Bundle)

Pharma Disease Insights: Oncology (Document Bundle)

$299.00

Add to Cart
  


Immediate download
Editable with PDF editor
Free lifetime updates

DESCRIPTION

This product (Pharma Disease Insights: Oncology) is a Document Bundle, which you can download immediately upon purchase.

As the pharma industry evolves, it's important to know you are basing your decisions on analysis that reflects the very latest trends and issues. With event-sensitive analysis, you can build your strategy based on analysis and forecasts that are reliable and accurate, to give you the tools to rapidly respond to changes across key diseases areas, companies and drugs.

Evaluate your drug's clinical and commercial potential against related treatments based on emerging clinical trial results and treatment guidelines.

Prioritize market opportunities: Assess revenue potential, competitive threats, market catalysts, and untapped product development opportunities with most up-to-date, comprehensive coverage of drugs, companies, epidemiology, diseases, strategy, and pricing and reimbursement trends.

Identify unmet needs: Gauge the relative strength of upcoming drugs with our drug comparator tool. Identify untapped opportunities.

What's Included

INTRODUCTION
1. Key Findings
2. Market Share of Drug Classes in 2015 and 2025
3. Disease Market SWOT Analysis
ETIOLOGY AND PATHOPHYSIOLOGY
1. Key Findings
2. Expert Insight
3. Disease Overview
4. Disease Pathophysiology
5. Etiology
6. Pathophysiology
KEY PATHWAYS AND DRUG TARGETS
MARKET OUTLOOK
1. Key Findings
2. Expert Insight
3. Market Overview
4. What Factors Are Driving the Market
5. What Factors Are Constraining the Market


THERE ARE 5 PRODUCTS IN THIS BUNDLE:


Colorectal cancer therapy market will grow modestly from $8.4 billion in 2015 to $12.5 billion in 2025 in the seven major pharmaceutical markets under study. Growth will be... [read more]

Add to Cart View Details

Individual Price: $99.00

In 2015, major-market sales totaled $1.2 billion for gastric and gastroesophageal junction (GEJ) adenocarcinoma. We expect that major-market sales will rapidly increase... [read more]

Add to Cart View Details

Individual Price: $99.00

Yielding an mPFS of 6.9 months and MOS of 14.6 months, the Stupp regimen has been the efficacy yardstick and standard treatment protocol followed for newly diagnosed... [read more]

Add to Cart View Details

Individual Price: $99.00

The multiple myeloma market will witness an impressive 10% annual growth over 2015-2025, with major-market sales increasing from $8.6 billion in 2015 to $22.3 billion in 2025.... [read more]

Add to Cart View Details

Individual Price: $99.00

The breast cancer therapy market was the largest in oncology across the major markets (United States, France, Germany, Italy, Spain, United Kingdom, and Japan) in 2015... [read more]

Add to Cart View Details

Individual Price: $99.00

Got a question about the product? Email us at support@flevy.com or ask the author directly by using the "Ask the Author a Question" form.


$299.00

Add to Cart
  

ABOUT THE AUTHOR

Author: BigPharma2000
Additional documents from author: 41

Ask the Author a Question

Must be logged in

Did you know?
The average daily rate of a McKinsey consultant is $6,625 (not including expenses). The average price of a Flevy document is $65.




Trusted by over 10,000+ Client Organizations
Since 2012, we have provided best practices to over 10,000 businesses and organizations of all sizes, from startups and small businesses to the Fortune 100, in over 130 countries.
AT&T GE Cisco Intel IBM Coke Dell Toyota HP Nike Samsung Microsoft Astrazeneca JP Morgan KPMG Walgreens Walmart 3M Kaiser Oracle SAP Google E&Y Volvo Bosch Merck Fedex Shell Amgen Eli Lilly Roche AIG Abbott Amazon PwC T-Mobile Broadcom Bayer Pearson Titleist ConEd Pfizer NTT Data Schwab




Read Customer Testimonials


Your Recently Viewed Documents
Document Bundle
$299.00 Bundle of 5 Documents


Customers Also Like These Documents

Related Management Topics


Healthcare Cancer Integrated Financial Model Value Chain Analysis

Download our FREE Strategy & Transformation Framework Templates

Download our free compilation of 50+ Strategy & Transformation slides and templates. Frameworks include McKinsey 7-S Strategy Model, Balanced Scorecard, Disruptive Innovation, BCG Experience Curve, and many more.